Healthcare Services

CRISPR technology market projected to reach $6.92B by 2030 at 22.2% CAGR

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The CRISPR Technology Market Over The 2026–2030 Period?

The crispr technology market has seen its size expand significantly over recent years. It is anticipated to expand from $2.53 billion in 2025 to $3.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.0%. The expansion observed historically is attributable to the breakthrough discovery of crispr cas systems, the limitations of conventional gene editing tools, rapid academic research adoption, declining sequencing costs, and strong public research funding.

The crispr technology market size is projected to experience substantial expansion in the coming years. It is forecast to reach $6.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.2%. This anticipated growth during the forecast period stems from factors such as clinical translation of gene editing therapies, the rise of precision medicine, the proliferation of gene-edited crops, breakthroughs in delivery technologies, and more robust regulatory frameworks. Key trends for the forecast period encompass the broadening of therapeutic gene editing applications, increased uptake in agricultural biotechnology, greater utilization in functional genomics research, surging demand for advanced delivery systems, and an emphasis on enhancing precision and minimizing off-target reduction.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

What Key Drivers Are Fueling The Growth Of The CRISPR Technology Market?

The future expansion of the CRISPR technology market is anticipated to be driven by the rising volume of ongoing clinical trials. These trials represent investigative studies conducted on individuals to evaluate the safety and efficacy of novel medical treatments, devices, or methodologies. As a potent gene-editing instrument, CRISPR technology finds application in numerous clinical trials targeting diverse conditions such as cancer, blood disorders, inherited eye diseases, and infectious diseases. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Consequently, the expanding volume of active clinical trials serves as a catalyst for the growth of the CRISPR technology market.

What Are The Key Segment Divisions In The CRISPR Technology Market Segment Structure?

The crispr technology market covered in this report is segmented –

1) By Product Type: Design Tool, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products

2) By Application: Biomedical, Agriculture, Diagnostics, Other Applications

3) By End-User: Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Design Tools: CRISPR Design Software, sgRNA Design Tools, Bioinformatics Platforms

2) By Plasmid And Vector: Plasmid Vectors, Viral Vectors, Bacterial Vectors

3) By Cas9 And gRNA: Cas9 Proteins, Guide RNA (gRNA) Products, Cas9 Complexes

4) By Delivery System Products: Electroporation Systems, Lipid-Based Delivery Systems, Viral Delivery Systems, Nanoparticle-Based Delivery Systems

What Trends Are Influencing The CRISPR Technology Market?

Leading companies in the CRISPR technology market are concentrating on developing advanced gene editing instruments to boost precision in genomic modifications for applications spanning medicine, agriculture, and biotechnology. Gene-editing tools are technologies that facilitate exact alterations to an organism’s DNA, enabling the addition, deletion, or modification of genetic material. These tools, such as CRISPR-Cas9, allow for targeted gene changes, thereby advancing research in genetics, medicine, and biotechnology. For instance, in May 2024, Profluent Bio Inc., an Ireland-based AI-first protein design company, introduced OpenCRISPR-1 for editing the human genome. This offers significant advantages in gene editing by achieving a 95% reduction in off-target effects, which increases the accuracy of genetic modifications compared to conventional CRISPR systems. Moreover, its open-source design allows researchers globally to customize and optimize the tool for diverse uses, promoting ethical application and accelerating the creation of new therapies for genetic disorders.

Which Organizations Are Engaged In The CRISPR Technology Market?

Major companies operating in the crispr technology market are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

Get The Full CRISPR Technology Market Report:

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Which Region Represents The Largest Share Of The CRISPR Technology Market?

North America was the largest region in the CRISPR technology market in 2025. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the crispr technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized CRISPR Technology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Browse Through More Reports Similar to the Global CRISPR Technology Market 2026, By The Business Research Company

Plant Breeding And Crispr Plants Market Report 2026

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795